Gemtuzumab ozogamicin (Mylotarg) monotherapy for relapsed AML after hematopoietic stem cell transplant: efficacy and incidence of hepatic veno-occlusive disease (Q74428168)
Jump to navigation
Jump to search
scientific article published on 01 July 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Gemtuzumab ozogamicin (Mylotarg) monotherapy for relapsed AML after hematopoietic stem cell transplant: efficacy and incidence of hepatic veno-occlusive disease |
scientific article published on 01 July 2002 |
Statements
Gemtuzumab ozogamicin (Mylotarg) monotherapy for relapsed AML after hematopoietic stem cell transplant: efficacy and incidence of hepatic veno-occlusive disease (English)
D L Porter
E A Stadtmauer
C Sickles
P A Mangan
S J Schuster
D E Tsai
S Nasta